#Ibrance

Latonya Wilson Advocates for Better Understanding of Metastatic Breast Cancer

A study in mice suggests that therapies approved for breast cancer may also combat other types, including colorectal and stomach cancer.

The FDA is warning that these drugs used to treat advanced breast cancers may cause rare but severe inflammation of the lungs.

This summer I am bouncing, and though I am not posting stuff, I am still writing and looking for my voice and how I want my own story to go.

Angela “Jersi” Baker, 48, of Charlotte, North Carolina, has found a new life as a model promoting metastatic breast cancer awareness.

An ongoing study is assessing pediatric and young adult cancers that did not respond to initial treatments.

Ibrance appears safe and effective for men in real-world use.

The decision to sign up for a clinical trial is not easy; there are risks for everything we do in terms of health and wellness.

Being told my surgical appointments were at an end was my first kind of untangling from my frequent follow-ups at Sloan.

I am happy, despite the side effects, that I am doing this trial. It might one day by the standard of care for early-stage breast cancer.

Today, instead of volunteering at my kids’ school for Halloween, I am at Sloan for my pre-op testing and meeting with the surgeon.

There are more clinical trials than there are cancer patients willing to accept them.

Indication extended to include first-line treatment of HR-positive/HER2-negative advanced or metastatic disease.

It was tough to feel so sick again, and it did “trigger” me to think back to chemo and feeling that run-down and sick.

Weigh the benefits and risks of different types of therapy when considering treatment, the American Heart Association advises.

I am happy to be doing my small part in helping test a new class of drug for breast cancer patients.

Verzenio delayed disease progression among women with HR-positive/HER2-negative breast cancer.